Emmanuel dexterity: Trump and Macron chat

Emmanuel dexterity: Trump and Macron chat

Up next

Elon shot: will Musk’s mega-merger work?

This week Elon Musk announced the merger of two of his companies: SpaceX and xAI, which makes chatbots. Is the new firm viable? As migrant workers return home for lunar new year, the Chinese Communist Party tells migrant workers not to stay for too long. And our culture editor’s ...  Show more

Nukes of hazard: US-Russia arms treaty expires

The New START nuclear deal was signed in 2010 to restrict the number of strategic warheads and missiles America and Russia could amass. Will there be a new deal – and what will happen if not? How social media has helped fuel recruitment to cults. And our baldness correspondent br ...  Show more

Recommended Episodes

Emmanuel dexterity: Trump and Macron chat
Economist Podcasts

The meeting between France’s and America’s presidents had a familiarly chummy feel. We ask whether Emmanuel Macron’s charm offensive might have changed Donald Trump’s mind on security matters. Norway’s stocks of wild salmon are in trouble—owing in part to their farmed brethren (9 ...  Show more

The French reconnection: Macron in Britain
Economist Podcasts

Anglo-French relations have not been so good since before the Brexit vote. Beneath the state-visit pageantry, though, there is much co-operation for President Emmanuel Macron and Prime Minister Keir Starmer to discuss. Gangs have infiltrated many of Latin America’s mining operati ...  Show more

Degrees of freedom? Harvard’s shakedown dilemma
Economist Podcasts

Donald Trump’s mission to bend higher education to his will maintains its sharpest focus on Harvard. Will the venerable university settle—and should it? Our correspondents meet with France’s top general, who believes Russia will threaten Europe sooner than many people think. And ...  Show more

Don wan: Harris keeps Trump tame
Economist Podcasts

The vice-president turned in a confident if imperfect performance, leaving Donald Trump flustered. But will it change anything? A global shortfall of blood plasma is hampering the development of new medicines; we argue for some simple market forces that could plug the gap (11:40) ...  Show more